A1AI0

2-chloro-3-{[{[1-(2-fluorophenyl)cyclopentyl]methyl}(4-{[1-(3-fluoropropyl)azetidin-3-yl]oxy}phenyl)amino]methyl}phenol

Created:	2024-03-27
Last modified:	2025-08-27

Find Related PDB Entry
1 entries where A1AI0 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	73
Chiral Atom Count	0
Bond Count	77
Aromatic Bond Count	18

2D diagram of A1AI0

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-chloro-3-{[{[1-(2-fluorophenyl)cyclopentyl]methyl}(4-{[1-(3-fluoropropyl)azetidin-3-yl]oxy}phenyl)amino]methyl}phenol
Systematic Name (OpenEye OEToolkits)	2-chloranyl-3-[[[4-[1-(3-fluoranylpropyl)azetidin-3-yl]oxyphenyl]-[[1-(2-fluorophenyl)cyclopentyl]methyl]amino]methyl]phenol
Formula	C₃₁ H₃₅ Cl F₂ N₂ O₂
Molecular Weight	541.072
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	FCCCN1CC(Oc2ccc(cc2)N(Cc2cccc(O)c2Cl)CC2(CCCC2)c2ccccc2F)C1
SMILES	CACTVS	3.385	Oc1cccc(CN(CC2(CCCC2)c3ccccc3F)c4ccc(OC5CN(CCCF)C5)cc4)c1Cl
SMILES	OpenEye OEToolkits	2.0.7	c1ccc(c(c1)C2(CCCC2)CN(Cc3cccc(c3Cl)O)c4ccc(cc4)OC5CN(C5)CCCF)F
Canonical SMILES	CACTVS	3.385	Oc1cccc(CN(CC2(CCCC2)c3ccccc3F)c4ccc(OC5CN(CCCF)C5)cc4)c1Cl
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1ccc(c(c1)C2(CCCC2)CN(Cc3cccc(c3Cl)O)c4ccc(cc4)OC5CN(C5)CCCF)F
InChI	InChI	1.06	InChI=1S/C31H35ClF2N2O2/c32-30-23(7-5-10-29(30)37)19-36(22-31(15-3-4-16-31)27-8-1-2-9-28(27)34)24-11-13-25(14-12-24)38-26-20-35(21-26)18-6-17-33/h1-2,5,7-14,26,37H,3-4,6,15-22H2
InChIKey	InChI	1.06	IQQNTEIXXROPQR-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	176508666

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.